Magnetar Financial’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Magnetar Financial’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-724,177	Closed	-$43.5M	–	1518
2021 Q1	$43.5M	Buy	+724,177	New	+$26.2M	0.42%	41

Magnetar Financial's PAND Position: Q2 2021 in Review

Magnetar Financial sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 724,177 shares — an estimated $43.5M sold.

Magnetar Financial first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $43.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Magnetar Financial reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Magnetar Financial sold 724,177 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $43.5M.
Magnetar Financial first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Magnetar Financial's Pandion Therapeutics Inc. Common Stock position peaked at $43.5M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Magnetar Financial's 13F filing for Q2 2021, filed 6 Aug 2021.